Viatris Announces Regulatory Milestones Across its Drug Pipeline for 2025#United_States#Pittsburgh#FDA_Approvals#Viatris#drug_pipeline
Viatris Announces Regulatory Milestones Across its Drug Pipeline for 2025
Viatris Inc. reveals significant regulatory achievements, including FDA approvals and new applications for several important medications, underscoring its commitment to healthcare innovation.
third-news.com
December 18, 2025 at 12:14 PM
Viatris Announces Regulatory Milestones Across its Drug Pipeline for 2025#United_States#Pittsburgh#FDA_Approvals#Viatris#drug_pipeline
The Surge in Cancer Immunotherapy: $258 Billion Market Set for Growth Following FDA Approvals#USA#Vancouver#Cancer_Immunotherapy#Oncolytics_Biotech#FDA_Approvals
The Surge in Cancer Immunotherapy: $258 Billion Market Set for Growth Following FDA Approvals
The FDA's recent approvals have propelled the cancer immunotherapy market towards a projected $258 billion by 2031, transforming treatment approaches.
third-news.com
September 16, 2025 at 5:21 PM
The Surge in Cancer Immunotherapy: $258 Billion Market Set for Growth Following FDA Approvals#USA#Vancouver#Cancer_Immunotherapy#Oncolytics_Biotech#FDA_Approvals
CytoSorbents Announces Regulatory Progress for DrugSorb-ATR Device#United_States#Princeton#FDA_Approvals#CytoSorbents#DrugSorb-ATR
CytoSorbents Announces Regulatory Progress for DrugSorb-ATR Device
CytoSorbents Corporation reports on the regulatory advancements for DrugSorb-ATR, a device aimed at enhancing patient safety during surgeries. This update highlights FDA interactions and future submission plans.
third-news.com
September 16, 2025 at 11:26 AM
CytoSorbents Announces Regulatory Progress for DrugSorb-ATR Device#United_States#Princeton#FDA_Approvals#CytoSorbents#DrugSorb-ATR
Significant Growth Forecast for Biologic Therapeutics Market, Reaching $794.5 Billion by 2029#USA#Boston#Chronic_Diseases#FDA_Approvals#Biologic_Therapeutics
Significant Growth Forecast for Biologic Therapeutics Market, Reaching $794.5 Billion by 2029
The biologic therapeutics market is projected to rise from $499.2 billion in 2024 to $794.5 billion by 2029, driven by rising demand and innovative therapies.
third-news.com
July 28, 2025 at 7:13 PM
Significant Growth Forecast for Biologic Therapeutics Market, Reaching $794.5 Billion by 2029#USA#Boston#Chronic_Diseases#FDA_Approvals#Biologic_Therapeutics
Weekly Update: Must-Read Health Announcements from PR Newswire#United_States#New_York#Gene_Editing#FDA_Approvals#Health_Press_Release
Weekly Update: Must-Read Health Announcements from PR Newswire
This week’s recap highlights essential health press releases, covering breakthroughs in gene therapy, product approvals, and investment in healthcare innovation.
third-news.com
May 16, 2025 at 10:24 AM
Weekly Update: Must-Read Health Announcements from PR Newswire#United_States#New_York#Gene_Editing#FDA_Approvals#Health_Press_Release
US Medical Aesthetics Market Projected to Reach $16.38 Billion by 2030#United_States#Delray_Beach#Medical_Aesthetics#Aesthetic_Devices#FDA_Approvals
US Medical Aesthetics Market Projected to Reach $16.38 Billion by 2030
The medical aesthetics market in the US is slated to grow significantly, reaching $16.38 billion by 2030 driven by technological advancements and demographic trends.
third-news.com
April 9, 2025 at 2:29 PM
US Medical Aesthetics Market Projected to Reach $16.38 Billion by 2030#United_States#Delray_Beach#Medical_Aesthetics#Aesthetic_Devices#FDA_Approvals
Weekly Healthcare Highlights: Essential Press Releases You Cannot Miss#USA#New_York#Healthcare_Releases#FDA_Approvals#Cannabis_Research
Weekly Healthcare Highlights: Essential Press Releases You Cannot Miss
Catch up on the most crucial healthcare press releases from last week, including FDA approvals and innovative studies focusing on mental health and cannabis.
third-news.com
January 31, 2025 at 11:44 AM
Weekly Healthcare Highlights: Essential Press Releases You Cannot Miss#USA#New_York#Healthcare_Releases#FDA_Approvals#Cannabis_Research